Trial intelligence / Profile preview

CIRKALM cream versus placebo for anal pain

2007-006029-29Phase 4Completed

Sponsor
Pierre Fabre Laboratories
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of Cirkalm (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Change in average anal pain over the first 14 days. Started Jan 2008; status: completed.

02

Drugs

Cirkalm

Beyond the preview

Go deeper on 2007-006029-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006029-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call